IRIS
LAI, PIERO LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.830
AS - Asia 1.179
NA - Nord America 987
Continente sconosciuto - Info sul continente non disponibili 143
SA - Sud America 122
AF - Africa 27
OC - Oceania 4
Totale 12.292
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 9.634
US - Stati Uniti d'America 928
SG - Singapore 499
CN - Cina 303
VN - Vietnam 190
FR - Francia 91
BR - Brasile 72
BD - Bangladesh 66
HK - Hong Kong 41
DE - Germania 25
CA - Canada 22
FI - Finlandia 20
AR - Argentina 19
IN - India 13
MX - Messico 13
JP - Giappone 11
CH - Svizzera 10
GB - Regno Unito 10
IQ - Iraq 9
NL - Olanda 9
ZA - Sudafrica 9
ID - Indonesia 8
CO - Colombia 7
PH - Filippine 7
CR - Costa Rica 6
EC - Ecuador 6
JM - Giamaica 6
MA - Marocco 6
IE - Irlanda 5
RO - Romania 5
VE - Venezuela 5
AZ - Azerbaigian 4
EG - Egitto 4
PK - Pakistan 4
RU - Federazione Russa 4
AU - Australia 3
CL - Cile 3
HN - Honduras 3
KR - Corea 3
NI - Nicaragua 3
PL - Polonia 3
PY - Paraguay 3
TH - Thailandia 3
UA - Ucraina 3
UY - Uruguay 3
DZ - Algeria 2
ES - Italia 2
IL - Israele 2
JO - Giordania 2
KZ - Kazakistan 2
NP - Nepal 2
PE - Perù 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
ET - Etiopia 1
FJ - Figi 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KE - Kenya 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MR - Mauritania 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SE - Svezia 1
TC - Turks e Caicos 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.150
Salva come PNG Salva come JPEG
Città #
Genova 5.104
Genoa 2.689
Rapallo 952
Vado Ligure 768
San Jose 264
Singapore 261
Ashburn 129
Lauterbourg 81
Ho Chi Minh City 79
Beijing 48
Santa Clara 44
Hong Kong 39
Hanoi 37
New York 37
Council Bluffs 29
Bordighera 27
Frankfurt am Main 20
Helsinki 18
Los Angeles 18
Chicago 11
Dallas 11
Da Nang 10
Orem 10
São Paulo 10
Tianjin 10
Buffalo 8
Milan 8
Prato 8
Tokyo 8
Zurich 8
Atlanta 7
Galveston 7
Rome 7
Amsterdam 6
Jacksonville 6
San Francisco 6
Toronto 6
Bari 5
Haiphong 5
Johannesburg 5
Baku 4
Biên Hòa 4
Boardman 4
Bonn 4
Cedar Rapids 4
Charlotte 4
Dublin 4
Guangzhou 4
Houston 4
Mexico City 4
Philadelphia 4
Shenzhen 4
Vinh 4
Wilmington 4
Austin 3
Belo Horizonte 3
Calgary 3
Chennai 3
Denver 3
Florence 3
Jakarta 3
Lahore 3
London 3
Managua 3
Milwaukee 3
Montreal 3
Newark 3
Phoenix 3
San José 3
Santa Cruz 3
Temecula 3
Turin 3
Waco 3
Ahmedabad 2
Alessandria 2
Amman 2
Augusta 2
Baghdad 2
Barranquilla 2
Bear 2
Bedford 2
Bogotá 2
Bologna 2
Bountiful 2
Brasília 2
Bắc Giang 2
Bắc Ninh 2
Cagayan de Oro 2
Cairo 2
Can Tho 2
Cape Town 2
Casablanca 2
Catania 2
Charleston 2
Cincinnati 2
Des Moines 2
Dhaka 2
East Hartford 2
Elmira 2
Erbil 2
Totale 10.973
Salva come PNG Salva come JPEG
Nome #
Age-related differences in the accuracy of web query-based predictions of influenza-like illness 227
A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects? 225
A comprehensive analysis of Italian web pages mentioning squalene-based influenza vaccine adjuvants reveals a high prevalence of misinformation 213
An overview on the implementation of HPV vaccination in Europe 206
Do the omeprazole family compounds exert a protective effect against influenza-like illness? 193
Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines 192
Safety and tolerability of bivalent HPV vaccine: an Italian post-licensure study 187
Cost-benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria 184
Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy 181
Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly 180
An overview of current and potential use of information and communication technologies for immunization promotion among adolescents 177
Cause of death among people with AIDS in Liguria (Italy). A different pattern for intravenous drug users? 175
Burden of the 1999-2008 seasonal influenza epidemics in Italy: comparison with the H1N1v (A/California/07/09) pandemic. 175
Influenza vaccination: from epidemiological aspects and advances in research to dissent and vaccination policies 168
Molecular characterization of a new variant of rotavirus P[8]G9 predominant in a sentinel-based survey in central Italy 165
Long-term decline of (137)Cs concentration in honey in the second decade after the Chernobyl accident 165
Chlamydia trachomatis prevalence and chlamydial/ HPV co-infection among HPV-unvaccinated young Italian females with normal cytology 163
Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies 158
Benefit-cost evaluation of Influenza vaccination in the elderly in the Italian Region of Liguria 157
Aflunov: a prepandemic influenza vaccine 157
Neisseria meningitidis B vaccines 156
La vaccinazione universale dei bambini contro l’influenza con il vaccino Vaxigrip Tetra® in Italia: risultati di una valutazione di Health Technology Assessment (HTA) [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment] 156
Influenza vaccination in italian healthcare workers (2018–2019 season): Strengths and weaknesses. results of a cohort study in two large italian hospitals 156
Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy? 155
Burden of rotavirus associated and non-rotavirus-associated diarrhea among nonhospitalized individuals in central Italy: a 1-year sentinel-based epidemiological and virological surveillance 155
Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO®) 153
Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra® 152
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus 151
Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V® and Fluad®) in preventing hospitalization for influenza and pneumonia in the elderly. A matched case-control study 148
In-depth phylogenetic analysis of the hemagglutinin gene of influenza A(H3N2) viruses circulating during the 2016-2017 season revealed egg-adaptive mutations of vaccine strains 148
People living with undiagnosed HIV infection and a low CD4 count: Estimates from surveillance data, Italy, 2012 to 2014 147
Influenza Burden on Italian Paediatric Population: Five year Nation-wide Surveillance and Correlation between Epidemiological and Virological Data 144
Anamnestic response to administration of purified non-adsorbent hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres. 141
Heterogeneous estimates of influenza virus types A and B in the elderly: Results of a meta-regression analysis 141
Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study 140
A pharmacoeconomic appraisal of the strategy to tackle the H1N1v (A/California/07/09) pandemic in Italy: relevance of the CIRI-IV surveillance system. 139
Why the anti-meningococcal b vaccination during adolescence should be implemented in italy: An overview of available evidence 139
Valutazione della tollerabilità del vaccino anti-HPV nelle donne liguri 135
Utility of virosomal adjuvated influenza vaccines - a review of the literature. 134
Benefit-cost evaluation of Influenza vaccination in elderly people in Liguria, Italy 134
Virological investigation on aerosol from waste depuration plants 133
Neisseria meningitidis B vaccines: recent advances and possible immunization policies. 133
Influenza epidemiology in Italy two years after the 2009-2010 pandemic: Need to improve vaccination coverage 132
Influenza epidemiology in Italy two years after the 2009-2010 pandemic: Need to improve vaccination coverage. 131
How the knowledge of interactions between meningococcus and the human immune system has been used to prepare effective Neisseria meningitidis vaccines 123
PREVALENZA DEI TIPI DI HPV NELLE DONNE ITALIANE (16-26 ANNI) SOTTOPOSTE A SCREENING VOLONTARIO DEL CANCRO CERVICALE. VALUTAZIONE DELL’INCIDENZA CUMULATIVA E DELLA POSSIBILE ESTENSIONE DELLA VACCINAZIONE CON IL VACCINO BIVALENTE. 121
Assessment and prevention of radioactive risk due to 222Radon in commercial concerns of Genoa 119
Burden of typhoid fever and cholera: Similarities and differences. Prevention strategies for European travelers to endemic/epidemic areas 117
Influenza surveillance by general practitioners and paediatricians in the Italian region of Liguria in 1999-2002 117
Relevance of air condititioning for 222Radon concentration in commercial concerns of the Savona Province, Italy 116
Development of a sensitive real-time PCR for simultaneous detection and subtyping of influenza A and B viruses 116
Diminuzione delle coperture vaccinali per influenza: riflessi sull'epidemiologia stagionale 2012-13 in Liguria. 116
Utility of thymosin alpha-1 (Zadaxin) as a co-adjuvant in influenza vaccines: a review 116
NEW VERSUS OLD MENINGOCOCCAL GROUP B VACCINES: HOW THE NEW ONES MAY BENEFIT INFANTS & TODDLERS 113
Health Technology Assessment (HTA) of the introduction of additional cohorts for anti-meningococcal vaccination with quadrivalent conjugate vaccines in Italy 113
Burden dell’influenza nella popolazione italiana nel periodo compreso tra il 1999 e il 2004: correlazioni tra sorveglianza clinico-epidemiologica e caratterizzazione antigenica e molecolare dei virus influenzali 112
VIROLOGICAL SURVEILLANCE AS A TOOL FOR ASSESSING HUMAN PAPILLOMAVIRUS VACCINATION 111
Influenza vaccination of elderly: relaunch time 111
Weekly monitoring of Influenza Like Illness (ILI) and other acute respiratory infections (ARI) impact on pediatric population during the last two years in 10 Italian Regions. 110
Tubercolosis today: populations at risk 110
Prevalence of the Human Papillomavirus genotypes in Italian women undergoing voluntary cervical cancer screening: Evaluation of cumulative incidence from 16 to 26 years of age and evaluationof the effect of extending Italian vaccination policy with bivalent vaccine. 109
Relevance of main factor affecting Radon concentration in multi-storey buildings in Liguria (Northern Italy) 109
Neisseria meningitidis: pathogenetic mechanisms to overcome the human immune defences 109
Health Technology Assessment of meningococcal B vaccine (Trumenba®) in adolescent in Italy 109
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: influenza life-cycle and currently available drugs 104
Exploring case definitions and the natural history of respiratory syncytial virus in adult outpatients: First-season results of the RESPIRA-50 study 103
Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season 102
Live attenuated influenza vaccine-a review 102
Valutazione costi-benefici della vaccinazione influenzale in Liguria 101
Vaccination promotion within a framework of public health education 99
Tobacco smoking among students in an urban area in Northern Italy 99
Valutazione costi/benefici della vaccinazione influenzale negli anziani in Liguria (Italia) 95
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0] 94
EPIDEMIOLOGIA DELL’INFLUENZA IN ITALIA DOPO LA PANDEMIA 2009-10. NECESSITÀ DI MIGLIORARE LE COPERTURE VACCINALI. 93
Co-detection of respiratory pathogens among ILI patients: characterization of samples collected during the 2018/19 and 2019/20 pre-pandemic seasons 92
Hepatitis B immunization and anti-HBs quantitation: comparative performance of thirteen commercial immunoassays 91
Le vaccinazioni dell'adulto a rischio e dell'anziano 89
Implementazione dei tassi di copertura vaccinale antinfluenzale nel personale sanitario dell'A.U.O. San Martino di Genova durante la stagione 2005-06 89
No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020 89
Efficacia dei vaccini adiuvati e ricadute farmaco-economiche 88
Valutazione della copertura antinfluenzale in Liguria mediante somministrazione di questionario telefonico 88
Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine 86
Valutazione dell'impatto epidemiologico, sanitario ed aconomico della malattia da herpes zoster in Italia 85
Health Technology Assessment e vaccinazioni in Italia 84
Prevalenza dell’anti-HCV in pazienti plurioperati 84
Meningococcal B vaccination strategies and their practical application in Italy 84
Today's influenza vaccines. Why an adjuvant is needed and How it works 81
Influenza vaccination coverage in Italy in 1999-2013: impact on incidence of ILIs in the elderly. 79
Three seasons of enhanced safety surveillance of a cell culture-based quadrivalent influenza vaccine 78
HTA in vaccine prevention: application to vaccinations against invasive diseases. 78
Vaccinations for adults at risk and the elderly 75
The urban myth of the association between neurological disorders and vaccinations. 73
Enhanced Passive Safety Surveillance (EPSS) confirms an optimal safety profile of the use of MF59®-adjuvanted influenza vaccine in older adults: Results from three consecutive seasons 73
Influenza surveillance in the Italian region of Liguria in the winter of 1999-2000 by general practitioners and paediatricians: socio-economic implications 72
UTILIZZO DELL'HTA IN PREVENZIONE VACCINALE: APPLICAZIONE ALLE VACCINAZIONI CONTRO LE MALATTIE INVASIVE 66
Demographic and Socio-economic Determinants of Poor HIV-risk Perception at First HIV Diagnosis: Analysis of the HIV Surveillance Data, Italy 2010-2016 59
A Mobile App to Enhance Awareness of Vaccination in Adults With Psoriasis and Atopic Dermatitis: Development and Preliminary Evaluation Study 43
A Mobile App to Enhance Awareness of Vaccination in Adults With Psoriasis and Atopic Dermatitis: Development and Preliminary Evaluation Study (Preprint) 43
The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment 25
A Cluster Randomized Study to Explore Case Definitions, Clinical Course and Consequences of RSV in Community-Dwelling Adults Aged ≥ 50 Years 12
Totale 12.276
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.803
article - articoli 34.309
book - libri 0
conference - conferenze 6.062
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 432
Totale 81.606
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022995 21 98 74 96 48 45 55 252 63 77 41 125
2022/20231.138 110 81 16 106 175 211 4 76 176 6 164 13
2023/2024542 18 86 13 75 34 92 36 55 40 7 34 52
2024/20251.853 54 133 60 130 260 198 170 249 49 94 196 260
2025/20263.271 406 66 258 280 378 280 512 191 224 284 175 217
2026/2027278 278 0 0 0 0 0 0 0 0 0 0 0
Totale 12.292